- 专利标题： COMPOUNDS USEFUL AS KINASE INHIBITORS
-
申请号： EP16816363.2申请日： 2016-12-16
-
公开(公告)号： EP3390395A1公开(公告)日： 2018-10-24
- 发明人: GUISOT, Nicolas
- 申请人： Loxo Oncology Inc.
- 申请人地址： 281 Tresser Boulevard 9th Floor Stamford, Connecticut 06901 US
- 专利权人： Loxo Oncology Inc.
- 当前专利权人： Loxo Oncology Inc.
- 当前专利权人地址： 281 Tresser Boulevard 9th Floor Stamford, Connecticut 06901 US
- 代理机构： HGF Limited
- 优先权： GB201522245 20151216; GB201613945 20160815
- 国际公布： WO2017103611 20170622
- 主分类号： C07D405/14
- IPC分类号： C07D405/14 ; A61K31/415 ; A61K31/4155 ; C07D231/14 ; C07D401/04 ; C07D401/06 ; C07D403/04 ; C07D405/04 ; C07D405/06 ; C07D405/08 ; C07D413/06 ; A61P35/00
摘要：
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.
公开/授权文献
- EP3390395B1 COMPOUNDS USEFUL AS KINASE INHIBITORS 公开/授权日：2020-09-09
信息查询
